Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether once monthly (QM) dosing of darbepoetin alfa is non-inferior to that of once every 2 week (Q2W) dosing of darbepoetin alfa for the correction of anemi...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Amgen
NCT05398783 · Metabolic Disorders, Cancer, and more
NCT03050268 · Acute Leukemia, Adenomatous Polyposis, and more
NCT07547098 · Cardiovascular Diseases (CVD), Chronic Kidney Disease, and more
NCT07232537 · Chronic Kidney Disease, Type 2 Diabetes Mellitus
NCT05196035 · Chronic Kidney Disease, Proteinuria
Research Site
Gosford, New South Wales
Research Site
Liverpool, New South Wales
Research Site
New Lambton, New South Wales
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions